课题基金 / 基金详情

Development of therapeutic strategy for allergic disorder on the basis of genome informations

Development of therapeutic strategy for allergic disorder on the basis of genome informations
基于基因组信息开发过敏性疾病治疗策略
批准号:
14370165
负责人:
KUBO Masato
金额:
$8.7万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2004

项目摘要

项目成果

KUBO Masato的其他基金

相似基金

相关文献

中文摘要
翻译
在经济发达之后,花粉症、哮喘、特应性皮炎等过敏性疾病成为日本城市严重的社会问题。虽然迄今为止,类固醇和免疫抑制剂通常用于过敏患者的治疗,但这些治疗在某些情况下会产生有害的副作用,因此未来有必要开发新的治疗策略来发挥更大的作用,而不是副作用。我们关注Th2的发育过程作为过敏性疾病的治疗靶点。在有限的细胞因子环境中,通过T细胞抗原受体(TCR)的初始激活信号对于辅助性T(Th)细胞发育的开始至关重要。细胞因子通过改变染色质构象调节关键转录因子T-bet和GATA-3的表达,指导Th1和Th2的分化方向。在这项研究中,我们研究了IL-4介导的信号转导在转基因小鼠体内的动力学,研究了在小鼠IL-4受体缺乏的背景下,更多地表达人IL-4受体(il - 4r Tg)。这些实验表明,在TCR介导的T细胞激活的早期阶段,IL-4信号是必需的,以实现谱系对Th2的承诺,以及IL-4位点内保守非编码序列(CNS)-1和-2中染色质的结构变化。在从初始CD4 T细胞向效应Th2细胞分化的过程中,Th2位点染色质结构的表观遗传变化与细胞因子表达谱密切相关。利用转基因的方法,我们研究了II4基因座上大量非编码序列的顺式作用活性。CNS-2对应于位于II4基因下游的Th2特异性重构位点,像CD4^+ T细胞一样调节CD62L^<lo> CD44^<hi>记忆中IL-4的初级产生。cns -2调控T细胞的耗竭导致Th2分化完全丧失。该CNS-2含有RBP-J的推定结合位点,RBP-J是Notch信号的关键调节剂。CD4 T细胞特异性RBP-J缺陷小鼠表现出像T细胞和Th2发育一样从记忆中消除初级IL-4的产生。因此,Notch/RBP-J信号介导的CNS-2调控对于Th2分化过程中IL-4的产生至关重要。少
英文摘要
After the advanced economic growth, allergic disease, such as pollinosis, asthma and Atopic dermatitis, seriously become social problem in urban area of Japan. Although a steroid and immunosuppressant agent are so far commonly used for the therapeutic treatment of allergic patients, these treatment carried on the harmful side effect in some case, thus the development of novel therapeutic strategy to function more than the side effect would be necessary in the future. We focus on Th2 developmental process as therapeutic target for allergic disease.An initial activation signal via the T cell antigen receptor(TCR) in a restricted cytokine environment is critical for the onset of helper T(Th) cell development. Cytokines regulate the expression of key transcriptional factors, T-bet and GATA-3,which instruct the direction of Th1 and Th2 differentiation, through changes in chromatin conformation. In this study, we investigated the kinetics of IL-4-mediated signaling in a transgenic mouse, exp … More ressing human IL-4 receptor (hIL-4R Tg) on a mouse IL-4 receptor deficient background. These experiments demonstrated that an IL-4 signal was required at the early stage of TCR mediated T cell activation for lineage commitment to Th2, along with structural change in chromatin, in conserved non-coding sequences (CNS)-1 and -2 within the IL-4 locus.Epigenetic changes in the chromatin structure of the Th2 locus tightly associate with cytokine expression profile during the differentiation process from naive CD4 T cells to effecter Th2 cells. Using a transgenic approach, we studied cis-acting activity of considerable conservation of noncording sequences on II4 locus. CNS-2 corresponding to Th2 specific-remodeling site located at downstream of II4 gene, regulated the primary IL-4 production in CD62L^<lo> CD44^<hi> memory like CD4^+ T cells. The depletion of the CNS-2-regulated T cells resulted complete loss of Th2 differentiation. This CNS-2 contains putative binding site for RBP-J, which is a critical modulator for Notch signaling. CD4 T cell specific RBP-J deficient mice showed abrogation of primary IL-4 production from the memory like T cells and Th2 development. Therefore, Notch/RBP-J signaling mediated CNS-2 regulation is a crucial for primary IL-4 production in Th2 differentiation. Less
期刊论文(50)
专著(0)
科研奖励(0)
会议论文
Regulation of αβ/γδ T cell lineage commitment and peripheral T cell response by Notch/RBP-J signaling.
通过 Notch/RBP-J 信号传导调节 αβ/γδ T 细胞谱系定型和外周 T 细胞反应。
DOI: --
发表时间: 2004
期刊: Immunity 20
影响因子: --
作者: [Tanigaki, K., Tsuji, M., Han, H., Yamamoto, N., Tsukada, J., Inoue, H., Kubo, M., Honjo, T.]
通讯作者: T.
Suppressor of cytokine signaling-1 (SOCS1) is essential for suppressing dendritic cell activation and systemic autoimmunity.
细胞因子信号传导抑制剂 1 (SOCS1) 对于抑制树突状细胞激活和系统性自身免疫至关重要。
DOI: --
发表时间: 2003
期刊: Immunity 19, 9
影响因子: --
作者: [Hanada, T., Inagaki-Ohara, K., Yoshida, H., KatoS., Tsukada, J., Nomura, Y., Mimata, H., Kubo, M., Yoshimura, A.]
通讯作者: A.
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
14
    Analysis of cytokines behavior in allergic disorder using in vivo imaging system
    • 批准号:
      24249058
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $29.37万
    • 财政年份:
      2012
    • 负责人:
      KUBO Masato
    • 依托单位:
    Understanding regulation of allergy by human single mutation using knock-in mouse line replacing with atopic type of human sequence
    • 批准号:
      23659243
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2011
    • 负责人:
      KUBO Masato
    • 依托单位:
    Genomics based approach for allergic disorderand development of innovative therapeutic strategy
    • 批准号:
      21390302
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.4万
    • 财政年份:
      2009
    • 负责人:
      KUBO Masato
    • 依托单位:
    Development of second generation therapeutic strategy based on genome information
    海外基金